[HTML][HTML] Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease
Alzheimer's disease (AD) is the most common neurodegenerative disorder seen in age-
dependent dementia. There is currently no effective treatment for AD, which may be …
dependent dementia. There is currently no effective treatment for AD, which may be …
Microglia in neurodegeneration
The neuroimmune system is involved in development, normal functioning, aging, and injury
of the central nervous system. Microglia, first described a century ago, are the main …
of the central nervous system. Microglia, first described a century ago, are the main …
[HTML][HTML] Landscape of intercellular crosstalk in healthy and NASH liver revealed by single-cell secretome gene analysis
Cell-cell communication via ligand-receptor signaling is a fundamental feature of complex
organs. Despite this, the global landscape of intercellular signaling in mammalian liver has …
organs. Despite this, the global landscape of intercellular signaling in mammalian liver has …
Inflammation in CNS neurodegenerative diseases
J Stephenson, E Nutma, P van der Valk, S Amor - Immunology, 2018 - Wiley Online Library
Neurodegenerative diseases, the leading cause of morbidity and disability, are gaining
increased attention as they impose a considerable socioeconomic impact, due in part to the …
increased attention as they impose a considerable socioeconomic impact, due in part to the …
[HTML][HTML] Tau and neuroinflammation in Alzheimer's disease: Interplay mechanisms and clinical translation
Y Chen, Y Yu - Journal of neuroinflammation, 2023 - Springer
Alzheimer's Disease (AD) contributes to most cases of dementia. Its prominent
neuropathological features are the extracellular neuritic plaques and intercellular …
neuropathological features are the extracellular neuritic plaques and intercellular …
[HTML][HTML] New insights into the role of TREM2 in Alzheimer's disease
Alzheimer's disease (AD) is the leading cause of dementia. The two histopathological
markers of AD are amyloid plaques composed of the amyloid-β (Aβ) peptide, and …
markers of AD are amyloid plaques composed of the amyloid-β (Aβ) peptide, and …
[HTML][HTML] Early-onset Alzheimer's disease: what is missing in research?
Abstract Purpose of Review Early-onset Alzheimer's disease (EOAD), defined as
Alzheimer's disease (AD) occurring before age 65, is significantly less well studied than the …
Alzheimer's disease (AD) occurring before age 65, is significantly less well studied than the …
Biomarkers used in Alzheimer's disease diagnosis, treatment, and prevention
YAR Mahaman, KS Embaye, F Huang, L Li, F Zhu… - Ageing research …, 2022 - Elsevier
Abstract Alzheimer's disease (AD), being the number one in terms of dementia burden, is an
insidious age-related neurodegenerative disease and is presently considered a global …
insidious age-related neurodegenerative disease and is presently considered a global …
[HTML][HTML] Inflammatory response in the CNS: friend or foe?
M Sochocka, BS Diniz, J Leszek - Molecular neurobiology, 2017 - Springer
Inflammatory reactions could be both beneficial and detrimental to the brain, depending on
strengths of their activation in various stages of neurodegeneration. Mild activation of …
strengths of their activation in various stages of neurodegeneration. Mild activation of …
[HTML][HTML] Late onset Alzheimer's disease genetics implicates microglial pathways in disease risk
AG Efthymiou, AM Goate - Molecular neurodegeneration, 2017 - Springer
Alzheimer's disease (AD) is a highly heritable complex disease with no current effective
prevention or treatment. The majority of drugs developed for AD focus on the amyloid …
prevention or treatment. The majority of drugs developed for AD focus on the amyloid …